Holdings of VANGUARD HEALTH CARE INDEX FUND
VANGUARD WORLD FUND · 408 declared positions · as of Feb 28, 2026
Original filing · Net assets 20.3B $ · Ten largest lines: 50.5 % of the equity sleeve
Sector breakdown
- Health care 84.9 %
- Materials 0.5 %
- Technology 0.4 %
- Consumer discretionary 0.3 %
- Industrials 0.2 %
- Unattributed 13.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 99.4 %
- IE 0.3 %
- BM 0.2 %
- CA 0.1 %
- VG 0.0 %
- NL 0.0 %
- SG 0.0 %
- JE 0.0 %
- KY 0.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 392 | 20.1B $ | 99.39 % |
| 2 | IE | 4 | 52M $ | 0.26 % |
| 3 | BM | 2 | 34M $ | 0.17 % |
| 4 | CA | 3 | 11.6M $ | 0.06 % |
| 5 | VG | 2 | 8.2M $ | 0.04 % |
| 6 | NL | 1 | 4.8M $ | 0.02 % |
| 7 | SG | 1 | 4.7M $ | 0.02 % |
| 8 | JE | 1 | 4.4M $ | 0.02 % |
| 9 | KY | 2 | 2.7M $ | 0.01 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 201 | CorVel Corp | 92,188 | 4.8M $ | 0.02 % |
| 202 | Ardelyx Inc | 725,779 | 4.8M $ | 0.02 % |
| 203 | Apellis Pharmaceuticals Inc | 226,629 | 4.8M $ | 0.02 % |
| 204 | Vera Therapeutics Inc | 115,268 | 4.7M $ | 0.02 % |
| 205 | AtriCure Inc | 148,983 | 4.7M $ | 0.02 % |
| 206 | Kiniksa Pharmaceuticals International Plc | 104,651 | 4.7M $ | 0.02 % |
| 207 | WaVe Life Sciences Ltd | 334,197 | 4.7M $ | 0.02 % |
| 208 | Artivion Inc | 120,612 | 4.6M $ | 0.02 % |
| 209 | QuidelOrtho Corp | 203,424 | 4.6M $ | 0.02 % |
| 210 | UFP Technologies Inc | 21,923 | 4.6M $ | 0.02 % |
| 211 | Axogen Inc | 138,420 | 4.4M $ | 0.02 % |
| 212 | Novocure Ltd | 319,728 | 4.4M $ | 0.02 % |
| 213 | Enovis Corp | 171,267 | 4.4M $ | 0.02 % |
| 214 | Progyny Inc | 246,071 | 4.4M $ | 0.02 % |
| 215 | Ocular Therapeutix Inc | 478,485 | 4.3M $ | 0.02 % |
| 216 | Celcuity Inc | 38,252 | 4.3M $ | 0.02 % |
| 217 | CONMED Corp | 92,707 | 4.3M $ | 0.02 % |
| 218 | Intellia Therapeutics Inc | 306,922 | 4.2M $ | 0.02 % |
| 219 | Stoke Therapeutics Inc | 115,694 | 4.2M $ | 0.02 % |
| 220 | Novavax Inc | 415,421 | 4.2M $ | 0.02 % |
| 221 | Definium Therapeutics Inc | 240,768 | 4.2M $ | 0.02 % |
| 222 | Innoviva Inc | 180,655 | 4.1M $ | 0.02 % |
| 223 | Establishment Labs Holdings Inc | 52,485 | 4.1M $ | 0.02 % |
| 224 | Recursion Pharmaceuticals Inc | 1,099,178 | 4M $ | 0.02 % |
| 225 | Biohaven Ltd | 350,058 | 4M $ | 0.02 % |
| 226 | Mineralys Therapeutics Inc | 136,784 | 4M $ | 0.02 % |
| 227 | ANI Pharmaceuticals Inc | 53,650 | 4M $ | 0.02 % |
| 228 | Collegium Pharmaceutical Inc | 94,785 | 3.9M $ | 0.02 % |
| 229 | Nuvation Bio Inc | 667,444 | 3.9M $ | 0.02 % |
| 230 | LifeStance Health Group Inc | 526,228 | 3.8M $ | 0.02 % |
| 231 | NeoGenomics Inc | 385,729 | 3.8M $ | 0.02 % |
| 232 | PROCEPT BIOROBOTICS CORP | 166,491 | 3.8M $ | 0.02 % |
| 233 | US Physical Therapy Inc | 45,359 | 3.8M $ | 0.02 % |
| 234 | Amylyx Pharmaceuticals Inc | 246,541 | 3.7M $ | 0.02 % |
| 235 | Relay Therapeutics Inc | 361,043 | 3.7M $ | 0.02 % |
| 236 | Harmony Biosciences Holdings Inc | 129,197 | 3.7M $ | 0.02 % |
| 237 | Nurix Therapeutics Inc | 227,843 | 3.6M $ | 0.02 % |
| 238 | Surgery Partners Inc | 232,138 | 3.6M $ | 0.02 % |
| 239 | Iovance Biotherapeutics Inc | 925,454 | 3.6M $ | 0.02 % |
| 240 | Pennant Group Inc/The | 103,054 | 3.5M $ | 0.02 % |
| 241 | Azenta Inc | 123,714 | 3.3M $ | 0.02 % |
| 242 | Phibro Animal Health Corp | 60,637 | 3.3M $ | 0.02 % |
| 243 | EyePoint Inc | 186,653 | 3.3M $ | 0.02 % |
| 244 | Palvella Therapeutics Inc | 23,095 | 3.1M $ | 0.02 % |
| 245 | Corvus Pharmaceuticals Inc | 167,790 | 3.1M $ | 0.02 % |
| 246 | Trevi Therapeutics Inc | 256,138 | 3.1M $ | 0.02 % |
| 247 | BioLife Solutions Inc | 123,064 | 3M $ | 0.01 % |
| 248 | Xeris Biopharma Holdings Inc | 484,655 | 3M $ | 0.01 % |
| 249 | Fortrea Holdings Inc | 273,797 | 2.9M $ | 0.01 % |
| 250 | Enliven Therapeutics Inc | 98,572 | 2.9M $ | 0.01 % |
| 251 | Vir Biotechnology Inc | 317,494 | 2.9M $ | 0.01 % |
| 252 | MannKind Corp | 877,153 | 2.9M $ | 0.01 % |
| 253 | CareDx Inc | 152,135 | 2.9M $ | 0.01 % |
| 254 | Pacira BioSciences Inc | 128,410 | 2.8M $ | 0.01 % |
| 255 | Teladoc Health Inc | 532,825 | 2.8M $ | 0.01 % |
| 256 | Astrana Health Inc | 135,321 | 2.8M $ | 0.01 % |
| 257 | Olema Pharmaceuticals Inc | 113,615 | 2.7M $ | 0.01 % |
| 258 | Tilray Brands Inc | 337,884 | 2.7M $ | 0.01 % |
| 259 | Dianthus Therapeutics Inc | 47,904 | 2.6M $ | 0.01 % |
| 260 | Clover Health Investments Corp | 1,260,385 | 2.6M $ | 0.01 % |
| 261 | Zymeworks Inc | 112,792 | 2.6M $ | 0.01 % |
| 262 | AdaptHealth Corp | 285,941 | 2.6M $ | 0.01 % |
| 263 | Castle Biosciences Inc | 87,576 | 2.6M $ | 0.01 % |
| 264 | iRadimed Corp | 24,989 | 2.6M $ | 0.01 % |
| 265 | UroGen Pharma Ltd | 118,186 | 2.6M $ | 0.01 % |
| 266 | Certara Inc | 361,931 | 2.6M $ | 0.01 % |
| 267 | Arvinas Inc | 187,746 | 2.5M $ | 0.01 % |
| 268 | Omeros Corp | 204,515 | 2.5M $ | 0.01 % |
| 269 | Geron Corp | 1,444,719 | 2.4M $ | 0.01 % |
| 270 | Ventyx Biosciences Inc | 171,667 | 2.4M $ | 0.01 % |
| 271 | Rapport Therapeutics Inc | 82,151 | 2.4M $ | 0.01 % |
| 272 | Kodiak Sciences Inc | 87,302 | 2.3M $ | 0.01 % |
| 273 | Esperion Therapeutics Inc | 695,906 | 2.3M $ | 0.01 % |
| 274 | Schrodinger Inc/United States | 192,621 | 2.3M $ | 0.01 % |
| 275 | AnaptysBio Inc | 42,144 | 2.3M $ | 0.01 % |
| 276 | Xencor Inc | 181,669 | 2.3M $ | 0.01 % |
| 277 | Butterfly Network Inc | 609,882 | 2.3M $ | 0.01 % |
| 278 | Day One Biopharmaceuticals Inc | 215,744 | 2.3M $ | 0.01 % |
| 279 | Integra LifeSciences Holdings Corp | 199,829 | 2.3M $ | 0.01 % |
| 280 | Amphastar Pharmaceuticals Inc | 111,730 | 2.3M $ | 0.01 % |
| 281 | AMN Healthcare Services Inc | 115,980 | 2.3M $ | 0.01 % |
| 282 | Oruka Therapeutics Inc | 65,417 | 2.3M $ | 0.01 % |
| 283 | Phreesia Inc | 180,017 | 2.2M $ | 0.01 % |
| 284 | MBX Biosciences Inc | 67,179 | 2.2M $ | 0.01 % |
| 285 | Sana Biotechnology Inc | 512,461 | 2.2M $ | 0.01 % |
| 286 | Hinge Health Inc | 49,070 | 2.1M $ | 0.01 % |
| 287 | Theravance Biopharma Inc | 114,278 | 2.1M $ | 0.01 % |
| 288 | Talkspace Inc | 420,757 | 2M $ | 0.01 % |
| 289 | Precigen Inc | 532,042 | 2M $ | 0.01 % |
| 290 | Arbutus Biopharma Corp | 432,384 | 2M $ | 0.01 % |
| 291 | Annexon Inc | 358,662 | 2M $ | 0.01 % |
| 292 | Guardian Pharmacy Services Inc | 59,909 | 2M $ | 0.01 % |
| 293 | CytomX Therapeutics Inc | 371,652 | 2M $ | 0.01 % |
| 294 | Avanos Medical Inc | 140,953 | 2M $ | 0.01 % |
| 295 | Tactile Systems Technology Inc | 66,842 | 2M $ | 0.01 % |
| 296 | Kura Oncology Inc | 221,971 | 1.9M $ | 0.01 % |
| 297 | STAAR Surgical Co | 96,492 | 1.9M $ | 0.01 % |
| 298 | SI-BONE Inc | 123,190 | 1.9M $ | 0.01 % |
| 299 | Taysha Gene Therapies Inc | 410,659 | 1.9M $ | 0.01 % |
| 300 | Enhabit Inc | 130,745 | 1.8M $ | 0.01 % |